Definitive Healthcare profit margin DH
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- −72.3%
- Peer median
- 4.9%
Over the twelve months to Jun 30, 2026, Definitive Healthcare kept −72.3% of its revenue as net profit and a gross margin of 75.2%.
Five years earlier its net margin was 0.0%.
The median for 10 infrastructure software stocks of a similar size is 4.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −57.5% | −92.9% | 75.9% |
| FY2024 | n/a | n/a | 78.3% |
| FY2023 | −80.5% | n/a | 81.1% |
| FY2022 | −3.2% | −19.8% | 80.9% |
| FY2021 | −10.7% | −16.4% | 75.5% |
| FY2020 | 0.0% | −13.4% | 74.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −72.3% | n/a | n/a | |
| Q1 FY26 | −71.5% | n/a | n/a | |
| Q4 FY25 | −57.5% | n/a | −92.9% | |
| Q3 FY25 | −77.9% | n/a | n/a | |
| Q2 FY25 | n/a | n/a | n/a | |
| Q1 FY25 | n/a | n/a | n/a | |
| Q4 FY24 | n/a | n/a | n/a | |
| Q3 FY24 | n/a | n/a | n/a | |
| Q2 FY24 | n/a | n/a | n/a | |
| Q1 FY24 | −78.2% | −73.5 pts | n/a | |
| Q4 FY23 | −80.5% | −77.3 pts | n/a | |
| Q3 FY23 | −74.1% | −61.1 pts | n/a |
Against its peers
Companies in Software - Infrastructure nearest Definitive Healthcare's size, closest first, today.
| Company | Profit margin |
|---|---|
| DHDefinitive Healthcare | −72.3% |
| NTWKNetsol Technologies | 4.0% |
| EGANEGAIN | 9.7% |
| FATNFatpipe | n/m |
| CCLDCareCloud | 6.2% |
| WFCFWhere Food Comes From | 5.8% |
| MKLYMcKinley Acquisition | n/m |
| RBBNRibbon Communications | 2.0% |
| IDNIntellicheck | 13.0% |
| MKTWMarketwise | 0.7% |
| IIIVi3 Verticals | 3.9% |
| Peer median | 4.9% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Definitive Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.